4//SEC Filing
Kirschbaum Mark 4
Accession 0001104659-23-077656
CIK 0001130166other
Filed
Jul 2, 8:00 PM ET
Accepted
Jul 3, 4:56 PM ET
Size
5.7 KB
Accession
0001104659-23-077656
Insider Transaction Report
Form 4
Kirschbaum Mark
Chief Medical Officer
Transactions
- Award
Stock Option (right to buy)
2023-06-30+70,200→ 70,200 totalExercise: $0.59From: 2026-06-30Exp: 2033-06-30→ Common Stock (70,200 underlying)
Footnotes (1)
- [F1]The reporting person received an award of 70,200 options on June 30, 2023, which shall vest in full on June 30, 2026, provided, however, that if certain clinical milestones are achieved then such options shall vest in full earlier in connection with such achievement.
Documents
Issuer
Cyclacel Pharmaceuticals, Inc.
CIK 0001130166
Entity typeother
Related Parties
1- filerCIK 0001830211
Filing Metadata
- Form type
- 4
- Filed
- Jul 2, 8:00 PM ET
- Accepted
- Jul 3, 4:56 PM ET
- Size
- 5.7 KB